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In this issue...ESTOOLS, a project funded by the European Commission
(FP6), gathers expertise on human embryonic stem cells in 10
countries of the European Research Area. The ESTOOLS
outreach program uses Art extensively as the only universal
cross-cultural and cross-religion means of communication. In
his piece “Art and Human Embryonic Stem Cells: from the
bench to the high street,” Sebastien Duprat highlights the
‘Smile of a Stem Cell’ photo exhibition, a major component
of this program that aims to enhance the public dissemina-
tion of science.
Legislation in individual member states of the European
Union on human embryonic stem cell (hESC) research is as
divergent as the different cultural, ethical, and religious
views on the issue. In their article, “The changing landscape
of European and international regulation on embryonic
stem cell research,” Anja Elstner and her colleagues
summarize the information on the current status of interna-
tional hESC regulation. They draw information from a two-
day symposium held on the occasion of the public launch of
the European Human Embryonic Stem Cell Registry (hESCreg:
www.hescreg.eu) in January 2008 in Berlin. This symposium
provided participants with an overview of state-of-the-art
hESC research and legislation throughout Europe and in
selected regions of the world.
Development involves an interplay between various cell
types from their birth to their disappearance by differentia-
tion, migration, or death. Analyzing these interactions
provides insights into their roles during the formation of a
new organism. In their article titled “A new in vitro model
for stem cell differentiation and interaction,” Anke Smits
and her colleagues describe a model based on embryoid
bodies (EBs) generated from mouse embryonic stem (mES)
cells, which can be used to visualize the differentiation of
mES cells into specific cell types while at the same time
allowing controlled removal of this same cell population
using an enzyme-prodrug approach. This system can easily be
adapted to determine the fate and interaction of many
different cell types.
Human pluripotent cells are a great potential source of
cells for cell-based therapies; however, directing their
differentiation into the desired cell types with high purity
remains a challenge. In their paper “Micropatterning human
embryonic stem cells dissects the mesoderm and endo-
derm lineages,” Lawrence Lee and colleagues show that, in1873-5061/$ – see front matter © 2008 Published by Elsevier B.V.
doi:10.1016/j.scr.2009.01.001the presence of appropriate growth factors, control of colony
size using a microcontact printing technology is able to direct
hESC fate to either the mesoderm or the endoderm lineage.
Large colonies preferentially give rise to mesoderm, while
small colonies are biased toward definitive endoderm.
Maria Sundberg and her colleagues have compared the
cell surface molecules expressed on undifferentiated human
ESC (hESCs) and their neural derivatives, in order to detect
markers that will identify potential hESC contaminants in
differentiated neural populations. Their findings are
reported in their paper, “CD marker expression profiles of
human embryonic stem cells and their neural derivatives,
determined using flow cytometric analysis, reveal a novel
CD marker for exclusion of pluripotent stem cells.” The
authors report that CD326 expression levels were consis-
tently higher in all undifferentiated hESC lines than in neural
cell derivatives. In addition, CD326-positive hESCs produced
teratomas, whereas CD326-negative neural populations did
not, earmarking CD326 as a useful novel marker of
undifferentiated hESCs.
Human mesenchymal stem cells (MSC) hold great promise
for cellular replacement therapies. Despite their contribut-
ing to phenotypically distinct cells in multiple tissues,
controversy remains regarding whether the phenotype
switch results from a true differentiation process. Evan
Colletti and colleagues studied the events occurring during
the first 120 h after human MSC transplantation into a large
animal model in their paper entitled “Generation of tissue-
specific cells by MSC does not require fusion or donor to
host mitochondrial/membrane transfer.” They show that
MSC proliferate and rapidly initiate a differentiative process,
changing their phenotype into tissue-specific cells. The
authors also demonstrate that true differentiation, and not
cell fusion or transfer of mitochondria or membrane-derived
vesicles between transplanted and resident cells, is the
primary mechanism contributing to the change of phenotype
of MSC upon transplantation.
Recently, the laboratory of Gerd Hasenfuss and Kaomei
Guan reported the successful establishment of multipotent
adult germ-line stem cells (maGSCs) from cultured adult
mouse spermatogonial stem cells. In this study, entitled
“Generation of functional neurons and glia from multi-
potent adult mouse germline stem cells,” Katrin Streck-
fuss-Bömeke, Alla Vlasov, and colleagues extend these
96 Editorialstudies by describing the generation of maGSC-derived
proliferating neural precursor cells using growth factor-
mediated neural lineage induction. Upon further differentia-
tion, they formed functional neurons and glial cells, as
demonstrated by expression of lineage-restricted genes and
proteins and by electrophysiological properties. These datademonstrate the potential for maGSCs as a new stem cell
source for basic research and biomedical applications.Andrew Elefanty
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